 |
The Health In Harlem PodcastAuthor: healthinharlem
Hosted by Dr. Maurice Selby, the Health In Harlem Podcast is a weekly talk show that distributes evidence-based information that is vital to healthy living. We discuss everything from hypertension and diabetes, heart disease, mental health and well-being, sexual dysfunction, diet and nutrition and public health and policy that affects the health of everyone here and abroad. Health In Harlem is closely associated with WHCR 90.3FM where the show is broadcast every week Thursday from 7pm to 8pm. Learn more at www.whrc.org. Language: en Genres: Health & Fitness, Medicine Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
GLP-1 Update with Dr. Mary Elizabeth Patti
Episode 83
Friday, 21 November, 2025
GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound have exploded into public consciousness as “weight-loss shots”—but what do they actually do inside the body, who are they really for, and what are the risks and benefits beyond the before-and-after photos? In this episode of Health in Harlem, Dr. Maurice Selby and Reid Vero sit down with Dr. Mary Elizabeth Patti, endocrinologist and physician-scientist at Harvard and the Joslin Diabetes Center, to break down: How GLP-1 receptor agonists were developed and how they work Why obesity is a complex, biology-based disease—not a willpower problem Benefits beyond weight loss, including impact on diabetes, heart health, sleep apnea, kidney disease, and more CDC+1 Real-world barriers to access (cost, coverage, side effects, and equity concerns) Safety questions around compounded and micro-dosed GLP-1 products Diabetes Journals+1 Where GLP-1s fit alongside lifestyle changes and bariatric/metabolic surgery The conversation also touches on stigma, body image, and why decisions about GLP-1 therapy should always be individualized and made with a trusted clinician. Learn more about Health in Harlem & WHCR 90.3FM Health in Harlem Podcast home: Health in Harlem on Podbean Health In Harlem Health in Harlem on WHCR 90.3FM: Show page at WHCR 90.3FM WHCR 90.3 FM Health in Harlem on Apple Podcasts: The Health in Harlem Podcast listing Apple Podcasts Evidence-based resources on GLP-1 medications For listeners who want to dive deeper into GLP-1s, diabetes, obesity, and cardiometabolic health: CDC – Newer diabetes medicines (including GLP-1s): Overview of how GLP-1 medicines lower blood sugar, support weight loss, and protect the heart and kidneys CDC CDC – GLP-1 injectable use data brief (NHIS 2024): National data on GLP-1 use among adults with diabetes CDC+1 American Diabetes Association (ADA): Guidance on GLP-1 and dual GIP/GLP-1 drugs, including a statement cautioning against non–FDA-approved compounded products American Diabetes Association+1 Endocrine Society – Diabetes treatments & GLP-1 receptor agonists: Patient-focused explanations of how GLP-1s are used, including injectable and oral options Endocrine Society+1 American Association of Clinical Endocrinology (AACE): Updates on GLP-1s in obesity, metabolic dysfunction, and cancer risk reduction AACE+1 American Heart Association (AHA): Professional summaries on GLP-1s and cardiovascular and kidney risk reduction in people with type 2 diabetes professional.heart.org+1 National Library of Medicine (NCBI/MedlinePlus/StatPearls): In-depth clinical reviews of GLP-1 receptor agonists, their mechanisms, benefits, and adverse effects NCBI+2PMC+2 FDA – Safety concerns with unapproved GLP-1 products: Important information on risks of non-approved or compounded GLP-1 drugs marketed for weight loss
